ESCMID eLibrary
Search results
Icon explanation
Icon explanation
close
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
Found 24 results
-
P1261
In vitro activity of WCK 4282 (high-dose cefepime-tazobactam) against resistant subsets of Enterobacteriaceae collected worldwide (2014)
11 April 2016
Session: Cefepime-tazobactam
Relevance:100%
-
P1262
Antimicrobial activity of WCK 4282 (high-dose cefepime-tazobactam) tested against Gram-negative organisms from medical centres located in Europe and the Asia-Pacific region
11 April 2016
Session: Cefepime-tazobactam
Relevance:100%
-
P1263
WCK4282 (high-dose cefepime-tazobactam) antimicrobial activity against Gram-negative organisms from United States (USA) and Latin American medical centres (2014)
11 April 2016
Session: Cefepime-tazobactam
Relevance:100%
-
P0806
WCK 4282 (cefepime-tazobactam) MIC quality control ranges using a multi-laboratory study design
10 April 2016
Session: Antimicrobial susceptibility testing of Gram-negative bacteria
Relevance:100%
-
P0328
Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 14,850 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014)
09 April 2016
Session: Susceptibility trends for old and new antibiotics
Relevance:100%
-
P1513
Longitudinal assessment of tigecycline activity tested against Gram-positive and Gram-negative organisms from European medical centres: results from the SENTRY Programme (2004-2012)
28 April 2013
Session: Approaches to antibiotic resistance surveillance and large scale surveys
Relevance:100%
-
P1516
Antimicrobial susceptibility of Gram-negative bacteria causing urinary tract infections in European and United States hospitals (2009-2011)
28 April 2013
Session: Approaches to antibiotic resistance surveillance and large scale surveys
Relevance:100% -
P1620
Antimicrobial activity of ceftaroline combined with avibactam tested against contemporary (2012) bacteria collected from USA patients with acute bacterial skin and skin structure infections (ABSSSI)
28 April 2013
Session: New beta-lactams and beta-lactamase inhibitors
Relevance:100%
-
P1621
Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens (2008-2011)
28 April 2013
Session: New beta-lactams and beta-lactamase inhibitors
Relevance:100%
-
P1630
Antimicrobial activity of ceftolozane/tazobactam and comparator agents tested against Pseudomonas aeruginosa isolates from 14 European countries and Israel
28 April 2013
Session: New beta-lactams and beta-lactamase inhibitors
Relevance:100%
Search narrowed by
-
Topics
-
Type of material
-
Time period
